PPCB
Propanc Biopharma·NASDAQ
--
--(--)
--
--(--)
PPCB fundamentals
During Q2 2026, Propanc Biopharma (PPCB) reported revenue of --, a YoY change of 0.00%. Net income was -3.09M, a YoY change of -618.62%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | Q1,2026 | Q2,2026 | TTM |
|---|
Start Date | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- |
Operating Expenses | 1.20M -- | 1.44M -- | 807.13K -- | 511.75K -- | 448.87K -62.72% | 757.82K -47.27% | 571.73K -29.17% | 836.33K +63.42% | 909.42K +102.60% | 1.38M +82.58% | 607.17K +6.20% | 594.07K -28.97% | 383.16K -57.87% | 274.09K -80.19% | 427.95K -29.52% | 726.94K +22.36% | 486.03K +26.85% | 403.47K +47.20% | 502.18K +17.35% | 599.19K -17.57% | 572.83K +17.86% | 608.00K +50.69% | 386.21K -23.09% | 209.60K -65.02% | 417.22K -27.17% | 438.06K -27.95% | 420.87K +8.97% | 259.90K +24.00% | 290.79K -30.30% | 213.38K -51.29% | 53.13M +12523.63% | 3.65M +1302.56% | 4.67M +1507.20% | 3.65M +1612.77% | 65.10M -- |
Selling, General and Administrative Expenses | 631.41K -- | 395.44K -- | 723.99K -- | 352.84K -- | 384.60K -39.09% | 656.59K +66.04% | 511.82K -29.31% | 773.33K +119.17% | 833.41K +116.70% | 1.38M +109.56% | 542.09K +5.91% | 529.99K -31.47% | 323.11K -61.23% | 216.18K -84.29% | 373.83K -31.04% | 639.95K +20.75% | 431.74K +33.62% | 346.16K +60.13% | 443.63K +18.67% | 484.92K -24.23% | 465.13K +7.73% | 525.62K +51.84% | 311.82K -29.71% | 197.31K -59.31% | 393.83K -15.33% | 318.19K -39.46% | 348.84K +11.87% | 227.09K +15.10% | 229.08K -41.83% | 153.59K -51.73% | 53.07M +15112.70% | 3.61M +1490.50% | 4.61M +1913.90% | 3.63M +2262.20% | 64.92M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.55M -- | -- -- | -- -- | -- -- | 1.71M +9.88% | -- -- | -- -- | -- -- | 1.50M -12.11% | 393.83K -- | 318.19K -- | 348.84K -- | 192.94K -87.14% | 220.76K -43.95% | 153.59K -51.73% | 53.07M +15112.70% | 3.59M +1758.24% | 4.60M +1983.07% | 3.63M +2262.20% | 64.88M -- |
Research and Development Expenses | 563.74K -- | 1.03M -- | 75.14K -- | 152.12K -- | 56.19K -90.03% | 94.78K -90.84% | 52.66K -29.92% | 56.71K -62.72% | 65.37K +16.33% | 37 -99.96% | 57.48K +9.17% | 57.09K +0.68% | 50.85K -22.22% | 50.16K +135481.08% | 44.89K -21.91% | 85.06K +48.98% | 46.55K -8.44% | 50.75K +1.17% | 50.40K +12.27% | 108.35K +27.38% | 101.33K +117.65% | 74.88K +47.53% | 66.02K +31.01% | 5.70K -94.74% | 16.24K -83.97% | 114.02K +52.28% | 65.45K -0.87% | 52.39K +819.77% | 61.71K +279.97% | 54.39K -52.30% | 54.10K -17.34% | 53.52K +2.16% | 60.20K -2.45% | 19.96K -63.30% | 187.78K -- |
Other Operating Expenses | 8.83K -- | 6.90K -- | 8.01K -- | 6.79K -- | 8.08K -8.52% | 6.45K -6.52% | 7.25K -9.46% | 6.29K -7.37% | 10.63K +31.62% | 7.59K +17.72% | 7.59K +4.73% | 6.99K +11.25% | 9.20K -13.43% | 7.75K +2.08% | 9.23K +21.60% | 1.93K -72.45% | 7.74K -15.95% | 6.55K -15.48% | 8.16K -11.63% | 5.92K +207.37% | 6.37K -17.62% | 7.51K +14.60% | 8.37K +2.55% | 6.60K +11.38% | 7.15K +12.18% | 5.86K -21.97% | 6.58K -21.36% | -19.58K -396.86% | -- -- | 5.40K -7.79% | 6.47K -1.66% | -20.19K -3.08% | -- -- | 6.60K +22.20% | -- -- |
Operating Income | -1.20M -- | -1.44M -- | -807.13K -- | -511.75K -- | -448.87K +62.72% | -757.82K +47.27% | -571.73K +29.17% | -836.33K -63.42% | -909.42K -102.60% | -1.38M -82.58% | -607.17K -6.20% | -594.07K +28.97% | -383.16K +57.87% | -274.09K +80.19% | -427.95K +29.52% | -726.94K -22.36% | -486.03K -26.85% | -403.47K -47.20% | -502.18K -17.35% | -599.19K +17.57% | -572.83K -17.86% | -608.00K -50.69% | -386.21K +23.09% | -209.60K +65.02% | -417.22K +27.17% | -438.06K +27.95% | -420.87K -8.97% | -259.90K -24.00% | -290.79K +30.30% | -213.38K +51.29% | -53.13M -12523.63% | -3.65M -1302.56% | -4.67M -1507.20% | -3.65M -1612.77% | -65.10M -- |
Non-Operating Income (Loss) | -719.77K -- | -945.19K -- | -684.36K -- | -909.22K -- | -1.68M -132.86% | -809.19K +14.39% | -9.40K +98.63% | -764.40K +15.93% | -691.42K +58.75% | -483.37K +40.27% | -2.00M -21216.44% | 1.80M +335.27% | -42.38K +93.87% | -129.55K +73.20% | -102.06K +94.91% | -53.22K -102.96% | -4.63K +89.08% | -451.97K -248.88% | 39.71K +138.90% | -305.30K -473.62% | -44.47K -860.78% | -6.74K +98.51% | -425.32K -1171.14% | -537.25K -75.97% | 66.35K +249.23% | -274.94K -3982.26% | -106.11K +75.05% | -98.92K +81.59% | -63.52K -195.73% | -216.80K +21.15% | -938.63K -784.60% | -426.21K -330.89% | -164.17K -158.46% | 563.34K +359.84% | -965.68K -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -27.18K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -8.19K -- | -- -- | -- -- | -- -- | -99.11K -1110.74% | -- -- | -- -- | -- -- | -530.33K -435.09% | 226.21K -- | -47.43K -- | 70.21K -- | 67.55K +112.74% | 52.79K -76.66% | 5.02K +110.59% | -12.15K -117.31% | 193.97K +187.18% | -19.71K -137.33% | 681.44K +13469.06% | 843.55K -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 30.50K -- | -- -- | -- -- | -- -- | -42.40K -239.01% | -- -- | -- -- | -- -- | 5.88K +113.88% | -15.95K -- | 37.15K -- | -36.43K -- | 37.31K +533.95% | 8.42K +152.82% | -84.12K -326.46% | -12.49K +65.72% | -1.06K -102.84% | -34.70K -511.96% | -19.50K +76.82% | -67.74K -- |
Other Non-Operating Income (Loss) | 172.64K -- | -458.47K -- | 146.54K -- | -330.12K -- | -1.05M -709.10% | -314.22K +31.46% | 180.40K +23.11% | -759.20K -129.97% | -16.19K +98.46% | -37.29K +88.13% | -1.62M -998.07% | 2.04M +368.69% | 116.90K +821.85% | 28.29K +175.86% | 838 +100.05% | -46.09K -102.26% | 105.22K -9.98% | -274.07K -1068.95% | 207.08K +24611.46% | -55.74K -20.93% | 118.28K +12.41% | 91.87K +133.52% | -268.12K -229.47% | 101.43K +281.97% | 34.31K -70.99% | -211 -100.23% | -6.78K +97.47% | -113.77K -212.16% | -11.32K -132.99% | -18.76K -8790.52% | -809.95K -11844.46% | -364.60K -220.48% | 195.86K +1830.37% | -39.68K -111.54% | -1.02M -- |
Net Interest Expense | 892.40K -- | 486.71K -- | 830.90K -- | 579.09K -- | 624.53K -30.02% | 494.97K +1.70% | 189.81K -77.16% | 5.20K -99.10% | 675.22K +8.12% | 446.08K -9.88% | 384.67K +102.66% | 241.47K +4542.70% | 159.28K -76.41% | 157.83K -64.62% | 102.90K -73.25% | 29.44K -87.81% | 109.85K -31.03% | 177.91K +12.72% | 167.38K +62.66% | 108.05K +267.02% | 162.75K +48.15% | 98.60K -44.58% | 157.20K -6.08% | 114.23K +5.72% | 178.22K +9.50% | 264.45K +168.20% | 133.11K -15.32% | 90.00K -21.21% | 86.23K -51.62% | 118.94K -55.02% | 104.04K -21.84% | 254.53K +182.80% | 305.63K +254.44% | 58.92K -50.47% | 723.12K -- |
Interest Expense | 892.43K -- | 486.75K -- | 830.91K -- | 579.10K -- | 624.54K -30.02% | 494.99K +1.69% | 189.81K -77.16% | 5.20K -99.10% | 675.23K +8.12% | 446.08K -9.88% | 384.80K +102.73% | 242.27K +4556.35% | 159.28K -76.41% | 157.84K -64.62% | 102.90K -73.26% | 29.44K -87.85% | 109.85K -31.03% | 177.91K +12.72% | 167.38K +62.66% | 113.67K +286.09% | 162.75K +48.15% | 98.62K -44.57% | 157.21K -6.07% | 114.24K +0.51% | 178.23K +9.51% | 264.46K +168.17% | 133.14K -15.31% | 90.00K -21.22% | 86.23K -51.62% | 118.94K -55.02% | 104.04K -21.86% | 254.54K +182.81% | 305.65K +254.46% | 58.95K -50.43% | 723.19K -- |
Interest Income | 28 -- | 39 -- | 15 -- | 5 -- | 4 -85.71% | 23 -41.03% | 2 -86.67% | 2 -60.00% | 3 -25.00% | 3 -86.96% | 137 +6750.00% | 803 +40050.00% | -- -- | 1 -66.67% | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 5.61K -- | 2 -- | 17 -- | 8 -- | 9 -99.84% | 17 +750.00% | 16 -5.88% | 27 +237.50% | 0 -100.00% | 1 -94.12% | 0 -100.00% | 1 -96.30% | 7 -- | 19 +1800.00% | 37 -- | 64 -- |
Pretax Income From Continuing Operations | -1.92M -- | -2.38M -- | -1.49M -- | -1.42M -- | -2.12M -10.46% | -1.57M +34.22% | -581.13K +61.04% | -1.60M -12.65% | -1.60M +24.66% | -1.87M -19.14% | -2.61M -349.47% | 1.20M +175.24% | -425.55K +73.42% | -403.64K +78.38% | -530.01K +79.71% | -780.16K -164.78% | -490.66K -15.30% | -855.44K -111.93% | -462.47K +12.74% | -904.49K -15.94% | -617.29K -25.81% | -614.74K +28.14% | -811.52K -75.47% | -746.85K +17.43% | -350.87K +43.16% | -713.00K -15.98% | -526.98K +35.06% | -358.81K +51.96% | -354.31K -0.98% | -430.18K +39.67% | -54.07M -10159.95% | -4.07M -1034.70% | -4.84M -1265.40% | -3.09M -618.62% | -66.07M -- |
Income Tax Expense | -- -- | -180.28K -- | -485 -- | 1.46K -- | -- -- | -116.97K +35.12% | 726 +249.69% | 807 -44.61% | -108.89K -- | 143 +100.12% | -26.32K -3724.93% | 340 -57.87% | -- -- | -- -- | -112.28K -326.63% | -1.14K -434.71% | -- -- | -55.46K -- | 213 +100.19% | 273 +123.99% | -- -- | -129.32K -133.17% | -1.72K -905.63% | 1.20K +338.10% | -- -- | -128.62K +0.54% | -275 +83.97% | -237 -119.82% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Income Tax Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -113.42K -- | -- -- | -- -- | -- -- | -54.98K +51.53% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -129.13K -- | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- |
Net Income | -1.92M -- | -2.20M -- | -1.49M -- | -1.42M -- | -2.12M -10.46% | -1.45M +34.15% | -581.86K +60.98% | -1.60M -12.59% | -1.49M +29.79% | -1.87M -28.76% | -2.59M -344.38% | 1.20M +175.18% | -425.55K +71.48% | -403.64K +78.38% | -417.74K +83.84% | -779.02K -164.70% | -490.66K -15.30% | -799.98K -98.19% | -462.69K -10.76% | -904.76K -16.14% | -617.29K -25.81% | -485.42K +39.32% | -809.81K -75.02% | -748.04K +17.32% | -350.87K +43.16% | -584.38K -20.39% | -526.70K +34.96% | -358.58K +52.06% | -354.31K -0.98% | -430.18K +26.39% | -54.07M -10165.30% | -4.07M -1035.45% | -4.84M -1265.40% | -3.09M -618.62% | -66.07M -- |
Net Income Attributable to Owners of the Company | -1.92M -- | -2.20M -- | -1.49M -- | -1.42M -- | -2.12M -10.46% | -1.45M +34.15% | -581.86K +60.98% | -1.60M -12.59% | -1.49M +29.79% | -1.87M -28.76% | -2.59M -344.38% | 1.20M +175.18% | -425.55K +71.48% | -403.64K +78.38% | -417.74K +83.84% | -779.02K -164.70% | -490.66K -15.30% | -799.98K -98.19% | -462.69K -10.76% | -904.76K -16.14% | -617.29K -25.81% | -485.42K +39.32% | -809.81K -75.02% | -748.04K +17.32% | -350.87K +43.16% | -584.38K -20.39% | -526.70K +34.96% | -358.58K +52.06% | -354.31K -0.98% | -430.18K +26.39% | -54.07M -10165.30% | -4.07M -1035.45% | -4.84M -1265.40% | -3.09M -618.62% | -66.07M -- |
Preferred Stock Dividends | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 391.75K -- | 114.84K -- | 93.40K -- | 237.39K -- | 254.71K -34.98% | 389.24K +238.92% | 19.32K -79.31% | -- -- | 57.72K -77.34% | -- -- | -- -- | 15.80K -- | 0 -100.00% | -- -- | -- -- | 0 -100.00% | 0 -- | -- -- | -- -- | -- -- |
Other Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 142.57K -- | 34.59K -- | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 932.25K -- | -- -- |
Net Income Attributable to Common Stockholders | -1.92M -- | -2.20M -- | -1.49M -- | -1.42M -- | -2.12M -10.46% | -1.45M +34.15% | -581.86K +60.98% | -1.60M -12.59% | -1.49M +29.79% | -1.87M -28.76% | -2.59M -344.38% | 1.20M +175.18% | -425.55K +71.48% | -403.64K +78.38% | -417.74K +83.84% | -1.17M -197.24% | -605.50K -42.29% | -893.38K -121.33% | -700.08K -67.59% | -1.16M +0.96% | -1.01M -66.23% | -504.74K +43.50% | -809.81K -15.67% | -805.76K +30.51% | -493.44K +50.98% | -618.97K -22.63% | -542.50K +33.01% | -358.58K +55.50% | -354.31K +28.20% | -430.18K +30.50% | -54.07M -9866.33% | -4.07M -1035.45% | -4.84M -1265.40% | -4.02M -835.33% | -67.00M -- |
Other Comprehensive Income | -189.59K -- | 19.33K -- | 198.63K -- | 471.31K -- | 276.22K +245.69% | 358.28K +1753.58% | -115.57K -158.18% | 190.14K -59.66% | 563.69K +104.07% | -629.49K -275.70% | 2.28M +2074.24% | -2.02M -1159.79% | -75.75K -113.44% | -167.76K +73.35% | 29.72K -98.70% | 31.33K +101.55% | 64.19K +184.74% | -7.70K +95.41% | -55.10K -285.36% | 147.94K +372.22% | 126.40K +96.90% | -107.81K -1300.70% | 40.61K +173.71% | 1.13K -99.24% | 73.67K -41.71% | -134.48K -24.74% | 105.38K +159.47% | -69.87K -6288.57% | -98.94K -234.30% | 321.23K +338.87% | -27.31K -125.92% | -145.64K -108.45% | 17.04K +117.23% | -7.85K -102.44% | -163.75K -- |
Total Comprehensive Income | -2.11M -- | -2.18M -- | -1.29M -- | -951.12K -- | -1.85M +12.52% | -1.09M +49.98% | -697.42K +46.04% | -1.41M -48.39% | -928.25K +49.79% | -2.50M -128.68% | -304.09K +56.40% | -811.10K +42.53% | -501.30K +46.00% | -571.41K +77.11% | -388.01K -27.60% | -1.14M -40.48% | -541.31K -7.98% | -901.07K -57.69% | -755.17K -94.62% | -1.01M +11.23% | -880.13K -62.59% | -612.55K +32.02% | -769.20K -1.86% | -804.63K +20.45% | -419.77K +52.31% | -753.45K -23.00% | -437.12K +43.17% | -428.45K +46.75% | -453.25K -7.98% | -108.95K +85.54% | -54.09M -12275.24% | -4.22M -884.28% | -4.82M -963.58% | -4.03M -3600.21% | -67.16M -- |
Total Comprehensive Income Attributable to Owners of the Company | -2.11M -- | -2.18M -- | -1.29M -- | -951.12K -- | -1.85M +12.52% | -1.09M +49.98% | -697.42K +46.04% | -1.41M -48.39% | -928.25K +49.79% | -2.50M -128.68% | -304.09K +56.40% | -811.10K +42.53% | -501.30K +46.00% | -571.41K +77.11% | -388.01K -27.60% | -1.14M -40.48% | -541.31K -7.98% | -901.07K -57.69% | -755.17K -94.62% | -1.01M +11.23% | -880.13K -62.59% | -612.55K +32.02% | -769.20K -1.86% | -804.63K +20.45% | -419.77K +52.31% | -753.45K -23.00% | -421.32K +45.23% | -621.41K +22.77% | -453.25K -7.98% | -108.95K +85.54% | -54.09M -12739.33% | -4.22M -578.64% | -4.82M -963.58% | -4.03M -3600.21% | -67.16M -- |
Basic EPS | -0.36 -- | -0.2 -- | -0.06 -- | -- -- | -10 -2677.78% | -41.33 -20565.00% | -0.89 -1383.33% | -- -- | -1.41 +85.90% | -1.25K -2926.32% | -348.75 -39085.39% | -- -- | -0.71 +49.65% | -0.45 +99.96% | -0.12 +99.97% | -- -- | -0.02 +97.18% | -0.02 +95.56% | -0.01 +91.67% | -- -- | -2.13 -10550.00% | -0.53 -2550.00% | -0.42 -4100.00% | -- -- | -0.04 +98.12% | -1.56K -294154.72% | -545.79 -129850.00% | -- -- | -35.97 -89825.00% | -32.23 +97.93% | -12.5 +97.71% | -- -- | -0.39 +98.92% | -0.3 +99.07% | -- -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.04 -- | -1.56K -- | -545.79 -- | -- -- | -35.97 -89825.00% | -32.23 +97.93% | -12.5 +97.71% | -- -- | -0.39 +98.92% | -0.3 +99.07% | -- -- |
Diluted EPS | -0.36 -- | -0.2 -- | -0.06 -- | -- -- | -10 -2677.78% | -41.33 -20565.00% | -0.89 -1383.33% | -- -- | -1.41 +85.90% | -1.25K -2926.32% | -348.75 -39085.39% | -- -- | -0.71 +49.65% | -0.45 +99.96% | -0.12 +99.97% | -- -- | -0.02 +97.18% | -0.02 +95.56% | -0.01 +91.67% | -- -- | -2.13 -10550.00% | -0.53 -2550.00% | -0.42 -4100.00% | -- -- | -0.04 +98.12% | -1.56K -294154.72% | -545.79 -129850.00% | -- -- | -35.97 -89825.00% | -32.23 +97.93% | -12.5 +97.71% | -- -- | -0.39 +98.92% | -0.3 +99.07% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.04 -- | -1.56K -- | -545.79 -- | -- -- | -35.97 -89825.00% | -32.23 +97.93% | -12.5 +97.71% | -- -- | -0.39 +98.92% | -0.3 +99.07% | -- -- |
You can ask Aime
What is Propanc Biopharma's gross profit margin?What were the key takeaways from Propanc Biopharma’s earnings call?What is the revenue and EPS growth rate for Propanc Biopharma year over year?What does Propanc Biopharma do and what are its main business segments?What is the market's earnings forecast for Propanc Biopharma next quarter?What is Propanc Biopharma's latest dividend and current dividend yield?What were the key takeaways from Propanc Biopharma's earnings call?What guidance did Propanc Biopharma's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
